Literature DB >> 17030446

Elevated circulating oxidized LDL levels in Japanese subjects with the metabolic syndrome.

Sho-ichi Yamagishi, Hidehiro Matsuoka, Soichi Kitano, Nozomu Hibi, Yuko Jinnouchi, Hidekazu Umei, Shuji Iida, Katsuhiko Takenaka, Takanori Matsui, Kazuo Nakamura, Tsutomu Imaizumi.   

Abstract

In the present study, we examined the relationship between circulating oxidized low-density lipoprotein (LDL) and the metabolic syndrome in Japanese patients. Subjects who had no histories of coronary or peripheral artery disease and were taking no medications (n=119; age 57+/-10 years; male/female, 90:29) underwent a complete history and physical examination, determination of blood chemistries and oxidized LDL levels. In stepwise regression analysis, triglycerides (p=0.0001) and HDL-cholesterol (p=0.0493, inversely) were independently correlated to oxidized LDL levels. Furthermore, a significant association (p<0.0001) was found between circulating oxidized LDL levels and the accumulation of the number of the components of the metabolic syndrome. Oxidized LDL levels were one of the independent determinants of intima-media thickness of the common carotid artery, a surrogate marker of atherosclerosis. The present study reveals that circulating oxidized LDL levels are strongly associated with the metabolic syndrome. Our results suggest that elevation of oxidized LDL may be a possible molecular link between accelerated atherosclerosis and the metabolic syndrome in Japanese subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030446     DOI: 10.1016/j.ijcard.2006.06.058

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.

Authors:  Paul Holvoet; Duk-Hee Lee; Michael Steffes; Myron Gross; David R Jacobs
Journal:  JAMA       Date:  2008-05-21       Impact factor: 56.272

2.  Oxidized LDL and the metabolic syndrome.

Authors:  Paul Holvoet; Dieuwke De Keyzer; David R Jacobs
Journal:  Future Lipidol       Date:  2008-12

3.  Association of inflammatory and oxidative stress markers with metabolic syndrome in asian indians in India.

Authors:  Veena S Rao; Radhika K Nagaraj; Sridhara Hebbagodi; Natesha B Kadarinarasimhiah; Vijay V Kakkar
Journal:  Cardiol Res Pract       Date:  2010-12-28       Impact factor: 1.866

4.  Oxidatively modified low-density lipoproteins are potential mediators of proteasome inhibitor resistance in multiple myeloma.

Authors:  Srikanth R Polusani; Valerie Cortez; Javier Esparza; Huynh Nga Nguyen; Hongxin Fan; Gopalrao V N Velagaleti; Matthew J Butler; Marsha C Kinney; Babatunde O Oyajobi; Samy L Habib; Reto Asmis; Edward A Medina
Journal:  Int J Cancer       Date:  2021-03-08       Impact factor: 7.316

5.  Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.

Authors:  Morihiro Matsuda; Ritsu Tamura; Kotaro Kanno; Takatsugu Segawa; Haruyuki Kinoshita; Orie Nishimoto; Hirohiko Nishiyama; Toshiharu Kawamoto
Journal:  Diabetol Metab Syndr       Date:  2013-12-06       Impact factor: 3.320

6.  Renin-angiotensin system impairs macrophage lipid metabolism to promote age-related macular degeneration in mouse models.

Authors:  Norihiro Nagai; Hirohiko Kawashima; Eriko Toda; Kohei Homma; Hideto Osada; Naymel A Guzman; Shinsuke Shibata; Yasuo Uchiyama; Hideyuki Okano; Kazuo Tsubota; Yoko Ozawa
Journal:  Commun Biol       Date:  2020-12-09

7.  OLR1 Gene Polymorphism and Oxidized LDL Levels in Metabolic Syndrome in Indian Population.

Authors:  Elvia Jamatia; Pramod Lali; B C Koner; D K Dhanwal; Mirza Masroor; Kritika Krishnamurthy; Aditi Singh
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.